Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled its annual shareholder meeting. The company’s 2022 Annual Meeting of Shareholders will begin at 10 a.m. ET on Aug. 15, 2022; the meeting will be held virtually. According to the announcement, notice of the annual meeting and a proxy…
Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for B2B cross-border shipping in the NAFTA region, has been awarded a contract with Samsung Mexico in regard to its SDS business. According to the announcement, FRGT has already started to use…
Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having a strong presence in Detroit not only enables us to keep up with the latest…
FingerMotion (NASDAQ: FNGR) is building a deeper channel for revenue in its services for China’s mobile phone users and big data clients. “FingerMotion’s central competencies are in mobile payment and mobile recharge platform solutions, but the company has been expanding into big data services through its Sapientus division. The data services have primarily been marketed…
DPCM Capital (NYSE: XPOA) recently entered into a definitive transaction agreement with D-Wave Systems Inc., whereby, upon closing of the transaction, shares of the pending parent company – D-Wave Quantum Inc. – are expected to trade on the NYSE under ticker symbol QBTS. D-Wave Systems, a leader in quantum computing systems, software and services, and…
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today urged shareholders to vote in favor of the proposals outlined in its definitive proxy statement for the upcoming annual shareholder meeting to be held Wednesday,…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the…
QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and pediatric patients,” a recent article reads. “CycloSam(R), QSAM Biosciences’ initial technology, is a clinical-stage bone…
Flora Growth’s (NASDAQ: FLGC) CEO Luis Merchan recently met with Senator Gustavo Bolivar, a Colombian representative who introduced a bill that creates the framework for recreational cannabis in the state. The bill was introduced on July 20, 2022, the same day that Merchan and Bolivar met. The two gentlemen met before Bolivar, a key author…
Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has been a key beneficiary of a trend that has seen hundreds of gambling platforms opt for white label product offerings from third-party providers. GMGI provides its end customers with access to a substantial portfolio of upwards of 10,000…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today issued a reminder for its current shareholders regarding the upcoming annual shareholder meeting. Beginning at 9:30 a.m. ET on July 26, 2022, Mullen will conduct a required formal shareholder meeting, which will be followed by a company presentation by David Michery, CEO and chairman…
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotherapeutics and other industries. The company today announced its entry into an agreement with North Star Holdings (“NSH”) on the financial partnership for the development, production, distribution and…
Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various conditions, has announced preliminary data from a feasibility study using Kernel Flow. The results indicate that ketamine-induced changes in functional connectivity last for several days after administration of the substance. “Kernel Flow is the first easy-to-use, wearable…
CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that its global clinical trial for a potentially pivotal brain cancer treatment will expand patient eligibility following an amendment to its protocol for the study. “CNS has been enrolling patients in its phase II clinical trial for novel drug candidate Berubicin, which has shown promise in fighting the aggressive…
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. The company is on a mission to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity. A recent article reads: “Fr8Tech leverages artificial intelligence to provide cloud-based platforms…
FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting its financial results for first quarter 2023, which is the period ending May 31, 2022. A highlight of the report showed a record quarterly revenue of $4.86 million; the report noted that that number included FNGR’s SMS & MMS and telecommunications products & services…
Flora Growth Corp. (NASDAQ: FLGC) is aggressively pushing its brand and advancing the conversation around cannabis. “In addition, with its able management, Flora is recognizing and capitalizing on opportunities that others are yet to identify, placing it in a unique position that not only gives it a first-mover advantage but also presents a unique opportunity…
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently entered into agreements with beverage developer BevNology. “The BevNology collaboration not only includes a commercial license agreement for products with active ingredients derived from hemp under BevNology’s brand but also a manufacturing operating agreement utilizing BevNology’s new, custom-built state-of-the-art processing facility outside…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform. “The Vancouver-based company started regionally in Western Canada with three owned and operated RNG and/or organic processing facilities as it pursues similar clusters throughout the country and seeks to lock down long-term RNG supply contracts.…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its appointment of Michael Woudenberg as chief operating officer of the company, overseeing all day-to-day operations. Woudenberg previously served as senior vice president of chemistry, manufacturing and controls. For the past several years, he has been an…